**Core Concept**
Non-specific esterase (NSE) is a marker used in the diagnosis of acute myeloid leukemia (AML), particularly to differentiate between monocytic and non-monocytic subtypes. NSE is a cytoplasmic enzyme that hydrolyzes ester bonds, and its presence is often associated with monocytic lineage.

**Why the Correct Answer is Right**
In AML, NSE positivity is commonly seen in monocytic and myelomonocytic subtypes, reflecting the monocytic lineage of these cells. The enzyme is usually localized to the cytoplasm of leukemic cells and is used as a diagnostic marker to identify monocytic differentiation. This helps in distinguishing between different subtypes of AML, such as M4 (myelomonocytic) and M5 (monocytic).

**Why Each Wrong Option is Incorrect**
**Option A:** Not directly related to the context of NSE positivity in AML.
**Option B:** Incorrect, as NSE positivity is indeed seen in myelomonocytic (M4) and monocytic (M5) subtypes of AML.
**Option C:** Incorrect, as NSE positivity is a characteristic feature of monocytic lineage, which is present in M5 (monocytic) AML.
**Option D:** Incorrect, as NSE positivity is not a specific marker for M3 (promyelocytic) AML, although it may be seen in some cases.

**Clinical Pearl / High-Yield Fact**
It is essential to note that NSE positivity is not exclusive to monocytic lineage and can be seen in other conditions, such as monocytic sarcoma and certain types of lymphoma. However, in the context of AML, NSE positivity is a useful marker for identifying monocytic differentiation.

**Correct Answer:** D.